Tevogen Bio Holdings Inc./$TVGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Ticker
$TVGN
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
18
ISIN
US88165K1016
Website
TVGN Metrics
BasicAdvanced
$216M
-
-$0.20
-0.80
-
Price and volume
Market cap
$216M
Beta
-0.8
52-week high
$1.51
52-week low
$0.89
Average daily volume
695K
Financial strength
Current ratio
0.353
Quick ratio
0.245
Long term debt to equity
-38.86
Total debt to equity
-62.458
Interest coverage (TTM)
-651.32%
Profitability
EBITDA (TTM)
-34.242
Management effectiveness
Return on assets (TTM)
-578.29%
Return on equity (TTM)
522.96%
Valuation
Price to book
-13.02
Price to tangible book (TTM)
-13.02
Price to free cash flow (TTM)
-13.593
Free cash flow yield (TTM)
-7.36%
Free cash flow per share (TTM)
-8.61%
Growth
Earnings per share change (TTM)
-91.08%
TVGN News
AllArticlesVideos
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
GlobeNewsWire·1 week ago
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
GlobeNewsWire·3 weeks ago
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tevogen Bio Holdings Inc. stock?
Tevogen Bio Holdings Inc. (TVGN) has a market cap of $216M as of June 27, 2025.
What is the P/E ratio for Tevogen Bio Holdings Inc. stock?
The price to earnings (P/E) ratio for Tevogen Bio Holdings Inc. (TVGN) stock is 0 as of June 27, 2025.
Does Tevogen Bio Holdings Inc. stock pay dividends?
No, Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Tevogen Bio Holdings Inc. dividend payment date?
Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Tevogen Bio Holdings Inc.?
Tevogen Bio Holdings Inc. (TVGN) has a beta rating of -0.8. This means that it has an inverse relation to market volatility.